TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers

Ram Shankar Mani, Matthew K. Iyer, Qi Cao, J. Chad Brenner, Lei Wang, Aparna Ghosh, Xuhong Cao, Robert J. Lonigro, Scott A. Tomlins, Sooryanarayana Varambally, Arul M. Chinnaiyan

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Recurrent gene fusions involving ETS family genes are a distinguishing feature of human prostate cancers, with TMPRSS2-ERG fusions representing the most common subtype. The TMPRSS2-ERG fusion transcript and its splice variants are well characterized in prostate cancers; however, not much is known about the levels and regulation of wild-type ERG. By employing an integrative approach, we show that the TMPRSS2-ERG gene fusion product binds to the ERG locus and drives the overexpression of wild-type ERG in prostate cancers. Knockdown of TMPRSS2-ERG in VCaP cells resulted in the downregulation of wild-type ERG transcription, whereas stable overexpression of TMPRSS2-ERG in the gene fusion-negative PC3 cells was associated with the upregulation of wild-type ERG transcript. Further, androgen signaling-mediated upregulation of TMPRSS2-ERG resulted in the concomitant upregulation of wild-type ERG transcription in VCaP cells. The loss of wild-type ERG expression was associated with a decrease in the invasive potential of VCaP cells. Importantly, 38% of clinically localized prostate cancers and 27% of metastatic prostate cancers harboring the TMPRSS2-ERG gene fusions exhibited overexpression of wild-type ERG. Taken together, these results provide novel insights into the regulation of ERG in human prostate cancers.

Original languageEnglish (US)
Pages (from-to)5387-5392
Number of pages6
JournalCancer Research
Volume71
Issue number16
DOIs
StatePublished - Aug 15 2011

Fingerprint

Prostatic Neoplasms
Gene Fusion
Up-Regulation
Androgens
Down-Regulation
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mani, R. S., Iyer, M. K., Cao, Q., Brenner, J. C., Wang, L., Ghosh, A., ... Chinnaiyan, A. M. (2011). TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. Cancer Research, 71(16), 5387-5392. https://doi.org/10.1158/0008-5472.CAN-11-0876

TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. / Mani, Ram Shankar; Iyer, Matthew K.; Cao, Qi; Brenner, J. Chad; Wang, Lei; Ghosh, Aparna; Cao, Xuhong; Lonigro, Robert J.; Tomlins, Scott A.; Varambally, Sooryanarayana; Chinnaiyan, Arul M.

In: Cancer Research, Vol. 71, No. 16, 15.08.2011, p. 5387-5392.

Research output: Contribution to journalArticle

Mani, RS, Iyer, MK, Cao, Q, Brenner, JC, Wang, L, Ghosh, A, Cao, X, Lonigro, RJ, Tomlins, SA, Varambally, S & Chinnaiyan, AM 2011, 'TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers', Cancer Research, vol. 71, no. 16, pp. 5387-5392. https://doi.org/10.1158/0008-5472.CAN-11-0876
Mani, Ram Shankar ; Iyer, Matthew K. ; Cao, Qi ; Brenner, J. Chad ; Wang, Lei ; Ghosh, Aparna ; Cao, Xuhong ; Lonigro, Robert J. ; Tomlins, Scott A. ; Varambally, Sooryanarayana ; Chinnaiyan, Arul M. / TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. In: Cancer Research. 2011 ; Vol. 71, No. 16. pp. 5387-5392.
@article{6b5deeba36da4f1287c2caf1f9016601,
title = "TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers",
abstract = "Recurrent gene fusions involving ETS family genes are a distinguishing feature of human prostate cancers, with TMPRSS2-ERG fusions representing the most common subtype. The TMPRSS2-ERG fusion transcript and its splice variants are well characterized in prostate cancers; however, not much is known about the levels and regulation of wild-type ERG. By employing an integrative approach, we show that the TMPRSS2-ERG gene fusion product binds to the ERG locus and drives the overexpression of wild-type ERG in prostate cancers. Knockdown of TMPRSS2-ERG in VCaP cells resulted in the downregulation of wild-type ERG transcription, whereas stable overexpression of TMPRSS2-ERG in the gene fusion-negative PC3 cells was associated with the upregulation of wild-type ERG transcript. Further, androgen signaling-mediated upregulation of TMPRSS2-ERG resulted in the concomitant upregulation of wild-type ERG transcription in VCaP cells. The loss of wild-type ERG expression was associated with a decrease in the invasive potential of VCaP cells. Importantly, 38{\%} of clinically localized prostate cancers and 27{\%} of metastatic prostate cancers harboring the TMPRSS2-ERG gene fusions exhibited overexpression of wild-type ERG. Taken together, these results provide novel insights into the regulation of ERG in human prostate cancers.",
author = "Mani, {Ram Shankar} and Iyer, {Matthew K.} and Qi Cao and Brenner, {J. Chad} and Lei Wang and Aparna Ghosh and Xuhong Cao and Lonigro, {Robert J.} and Tomlins, {Scott A.} and Sooryanarayana Varambally and Chinnaiyan, {Arul M.}",
year = "2011",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-11-0876",
language = "English (US)",
volume = "71",
pages = "5387--5392",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers

AU - Mani, Ram Shankar

AU - Iyer, Matthew K.

AU - Cao, Qi

AU - Brenner, J. Chad

AU - Wang, Lei

AU - Ghosh, Aparna

AU - Cao, Xuhong

AU - Lonigro, Robert J.

AU - Tomlins, Scott A.

AU - Varambally, Sooryanarayana

AU - Chinnaiyan, Arul M.

PY - 2011/8/15

Y1 - 2011/8/15

N2 - Recurrent gene fusions involving ETS family genes are a distinguishing feature of human prostate cancers, with TMPRSS2-ERG fusions representing the most common subtype. The TMPRSS2-ERG fusion transcript and its splice variants are well characterized in prostate cancers; however, not much is known about the levels and regulation of wild-type ERG. By employing an integrative approach, we show that the TMPRSS2-ERG gene fusion product binds to the ERG locus and drives the overexpression of wild-type ERG in prostate cancers. Knockdown of TMPRSS2-ERG in VCaP cells resulted in the downregulation of wild-type ERG transcription, whereas stable overexpression of TMPRSS2-ERG in the gene fusion-negative PC3 cells was associated with the upregulation of wild-type ERG transcript. Further, androgen signaling-mediated upregulation of TMPRSS2-ERG resulted in the concomitant upregulation of wild-type ERG transcription in VCaP cells. The loss of wild-type ERG expression was associated with a decrease in the invasive potential of VCaP cells. Importantly, 38% of clinically localized prostate cancers and 27% of metastatic prostate cancers harboring the TMPRSS2-ERG gene fusions exhibited overexpression of wild-type ERG. Taken together, these results provide novel insights into the regulation of ERG in human prostate cancers.

AB - Recurrent gene fusions involving ETS family genes are a distinguishing feature of human prostate cancers, with TMPRSS2-ERG fusions representing the most common subtype. The TMPRSS2-ERG fusion transcript and its splice variants are well characterized in prostate cancers; however, not much is known about the levels and regulation of wild-type ERG. By employing an integrative approach, we show that the TMPRSS2-ERG gene fusion product binds to the ERG locus and drives the overexpression of wild-type ERG in prostate cancers. Knockdown of TMPRSS2-ERG in VCaP cells resulted in the downregulation of wild-type ERG transcription, whereas stable overexpression of TMPRSS2-ERG in the gene fusion-negative PC3 cells was associated with the upregulation of wild-type ERG transcript. Further, androgen signaling-mediated upregulation of TMPRSS2-ERG resulted in the concomitant upregulation of wild-type ERG transcription in VCaP cells. The loss of wild-type ERG expression was associated with a decrease in the invasive potential of VCaP cells. Importantly, 38% of clinically localized prostate cancers and 27% of metastatic prostate cancers harboring the TMPRSS2-ERG gene fusions exhibited overexpression of wild-type ERG. Taken together, these results provide novel insights into the regulation of ERG in human prostate cancers.

UR - http://www.scopus.com/inward/record.url?scp=80051681322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051681322&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-0876

DO - 10.1158/0008-5472.CAN-11-0876

M3 - Article

VL - 71

SP - 5387

EP - 5392

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -